571 related articles for article (PubMed ID: 12124333)
1. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells.
Shimizu M; Suzui M; Deguchi A; Lim JT; Xiao D; Hayes JH; Papadopoulos KP; Weinstein IB
Clin Cancer Res; 2004 Oct; 10(19):6710-21. PubMed ID: 15475462
[TBL] [Abstract][Full Text] [Related]
3. Acyclic retinoid, a novel synthetic retinoid, induces growth inhibition, apoptosis, and changes in mRNA expression of cell cycle- and differentiation-related molecules in human colon carcinoma cells.
Suzui M; Sunagawa N; Chiba I; Moriwaki H; Yoshimi N
Int J Oncol; 2006 May; 28(5):1193-9. PubMed ID: 16596235
[TBL] [Abstract][Full Text] [Related]
4. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
Lu HQ; Zheng J
Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.
Zhu WY; Jones CS; Kiss A; Matsukuma K; Amin S; De Luca LM
Exp Cell Res; 1997 Aug; 234(2):293-9. PubMed ID: 9260897
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.
Flørenes VA; Lu C; Bhattacharya N; Rak J; Sheehan C; Slingerland JM; Kerbel RS
Oncogene; 1999 Jan; 18(4):1023-32. PubMed ID: 10023678
[TBL] [Abstract][Full Text] [Related]
7. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.
Park SE; Lee SW; Hossain MA; Kim MY; Kim MN; Ahn EY; Park YC; Suh H; Kim GY; Choi YH; Kim ND
Cancer Lett; 2008 Oct; 270(1):77-86. PubMed ID: 18554781
[TBL] [Abstract][Full Text] [Related]
8. Posttranslational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells.
Sueoka N; Lee HY; Walsh GL; Hong WK; Kurie JM
Cancer Res; 1999 Aug; 59(15):3838-44. PubMed ID: 10447003
[TBL] [Abstract][Full Text] [Related]
9. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
10. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
Tetsu O; McCormick F
Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
[TBL] [Abstract][Full Text] [Related]
11. Effects of acyclic retinoid on growth, cell cycle control, epidermal growth factor receptor signaling, and gene expression in human squamous cell carcinoma cells.
Shimizu M; Suzui M; Deguchi A; Lim JT; Weinstein IB
Clin Cancer Res; 2004 Feb; 10(3):1130-40. PubMed ID: 14871993
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ
Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173
[TBL] [Abstract][Full Text] [Related]
13. Acyclic retinoid synergises with valproic acid to inhibit growth in human hepatocellular carcinoma cells.
Tatebe H; Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Tsurumi H; Moriwaki H
Cancer Lett; 2009 Nov; 285(2):210-7. PubMed ID: 19520494
[TBL] [Abstract][Full Text] [Related]
14. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
[TBL] [Abstract][Full Text] [Related]
15. Acyclic retinoid activates retinoic acid receptor beta and induces transcriptional activation of p21(CIP1) in HepG2 human hepatoma cells.
Suzui M; Shimizu M; Masuda M; Lim JT; Yoshimi N; Weinstein IB
Mol Cancer Ther; 2004 Mar; 3(3):309-16. PubMed ID: 15026551
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).
Liu TZ; Chen CY; Yiin SJ; Chen CH; Cheng JT; Shih MK; Wang YS; Chern CL
Food Chem Toxicol; 2006 Feb; 44(2):227-35. PubMed ID: 16112786
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid and the cyclin dependent kinase inhibitors synergistically alter proliferation and morphology of U343 astrocytoma cells.
Dirks PB; Patel K; Hubbard SL; Ackerley C; Hamel PA; Rutka JT
Oncogene; 1997 Oct; 15(17):2037-48. PubMed ID: 9366521
[TBL] [Abstract][Full Text] [Related]
18. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression.
Quasnichka H; Slater SC; Beeching CA; Boehm M; Sala-Newby GB; George SJ
Circ Res; 2006 Dec; 99(12):1329-37. PubMed ID: 17122440
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells.
Li R; Faria TN; Boehm M; Nabel EG; Gudas LJ
Exp Cell Res; 2004 Mar; 294(1):290-300. PubMed ID: 14980522
[TBL] [Abstract][Full Text] [Related]
20. [Evidence for retinoic acid modulating expression of cyclin-dependent kinase inhibitors in rat hepatic stellate cells].
Huang G; Zhang J; Zhang Y
Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):306-8. PubMed ID: 11676881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]